Dai B, Han S, Shen Y, Li Z, Chen S, Wang Z
BMC Infect Dis. 2024; 24(1):972.
PMID: 39271984
PMC: 11395589.
DOI: 10.1186/s12879-024-09743-w.
Xie Q, Zhang X, Cui W, Pang Y
J Inflamm Res. 2022; 15:6495-6504.
PMID: 36474517
PMC: 9719700.
DOI: 10.2147/JIR.S387809.
Poddighe D, Demirkaya E, Sazonov V, Romano M
Int J Clin Pract. 2022; 2022:6343818.
PMID: 35855053
PMC: 9286979.
DOI: 10.1155/2022/6343818.
Tong L, Huang S, Zheng C, Zhang Y, Chen Z
J Clin Med. 2022; 11(10).
PMID: 35628949
PMC: 9144103.
DOI: 10.3390/jcm11102824.
Shi S, Zhang X, Zhou Y, Tang H, Zhao D, Liu F
Sci Rep. 2019; 9(1):7147.
PMID: 31073201
PMC: 6509254.
DOI: 10.1038/s41598-019-43451-9.
The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children.
Yan Y, Wei Y, Jiang W, Hao C
Sci Rep. 2016; 6:39929.
PMID: 28008989
PMC: 5180238.
DOI: 10.1038/srep39929.
Correlation between Radiological and Pathological Findings in Patients with Mycoplasma pneumoniae Pneumonia.
Tanaka H
Front Microbiol. 2016; 7:695.
PMID: 27242720
PMC: 4862977.
DOI: 10.3389/fmicb.2016.00695.
Antibody Response to Mycoplasma pneumoniae: Protection of Host and Influence on Outbreaks?.
Dumke R, Jacobs E
Front Microbiol. 2016; 7:39.
PMID: 26858711
PMC: 4726802.
DOI: 10.3389/fmicb.2016.00039.
Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.
Saraya T, Kurai D, Nakagaki K, Sasaki Y, Niwa S, Tsukagoshi H
Front Microbiol. 2014; 5:410.
PMID: 25157244
PMC: 4127663.
DOI: 10.3389/fmicb.2014.00410.
Role of IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae.
Kurata S, Osaki T, Yonezawa H, Arae K, Taguchi H, Kamiya S
BMC Microbiol. 2014; 14:156.
PMID: 24928272
PMC: 4074139.
DOI: 10.1186/1471-2180-14-156.
First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O, Klaver S, Schimke L, Ascendino E, Khan T, Pereira P
J Clin Immunol. 2014; 34(2):146-56.
PMID: 24402618
DOI: 10.1007/s10875-013-9980-4.
Mycoplasma pneumoniae in children with acute and refractory asthma.
Wood P, Hill V, Burks M, Peters J, Singh H, Kannan T
Ann Allergy Asthma Immunol. 2013; 110(5):328-334.e1.
PMID: 23622002
PMC: 3703852.
DOI: 10.1016/j.anai.2013.01.022.
Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.
Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T
J Infect. 2008; 57(3):223-8.
PMID: 18656264
PMC: 7112643.
DOI: 10.1016/j.jinf.2008.06.012.
Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl.
Daxboeck F, Eisl B, Burghuber C, Memarsadeghi M, Assadian O, Stanek G
Wien Klin Wochenschr. 2007; 119(11-12):379-84.
PMID: 17634897
PMC: 7102288.
DOI: 10.1007/s00508-007-0810-7.
Mycoplasma pneumoniae and its role as a human pathogen.
Waites K, Talkington D
Clin Microbiol Rev. 2004; 17(4):697-728, table of contents.
PMID: 15489344
PMC: 523564.
DOI: 10.1128/CMR.17.4.697-728.2004.
Animal model of Mycoplasma pneumoniae infection using germfree mice.
Hayakawa M, Taguchi H, Kamiya S, Fujioka Y, Watanabe H, Kawai S
Clin Diagn Lab Immunol. 2002; 9(3):669-76.
PMID: 11986276
PMC: 119980.
DOI: 10.1128/cdli.9.3.669-676.2002.
Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.
Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T
Clin Diagn Lab Immunol. 2000; 7(6):909-14.
PMID: 11063497
PMC: 95984.
DOI: 10.1128/CDLI.7.6.909-914.2000.
Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses.
Andersen P
Thorax. 1998; 53(4):302-7.
PMID: 9741376
PMC: 1745181.
DOI: 10.1136/thx.53.4.302.
Mycoplasma infections of the human respiratory tract.
Gupta U
Indian J Pediatr. 1993; 60(2):153-63.
PMID: 8244491
DOI: 10.1007/BF02822169.
Fulminant Mycoplasma pneumoniae pneumonia.
Chan E, Welsh C
West J Med. 1995; 162(2):133-42.
PMID: 7725685
PMC: 1022647.
